Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 15, 2004; 10(8): 1191-1197
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1191
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1191
Figure 5 Detection of endostatin in livers of tumor-bearing mice.
Hepatic tumors were induced by injecting murine sar-coma cells into the liver. After 7 d, the livers were harvested from the mice of different groups and analyzed by immuno-histochemical staining for endostatin. Livers without treatment, rAAV-LacZ alone and rAAV-LacZ plus etoposide pretreatment did not express endostatin. The vessels of livers treated with rAAV-endostatin were stained with anti-endostatin antibodies and a significant increase was observed in the rAAV-endostatin plus etoposide treatment group (arrow). Endostatin was also detected in hepatocytes of the rAAV-endostatin plus etoposide treatment group (arrow head).
- Citation: Hong SY, Lee MH, Kim KS, Jung HC, Roh JK, Hyung WJ, Noh SH, Choi SH. Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model. World J Gastroenterol 2004; 10(8): 1191-1197
- URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1191.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1191